Precision medicine platform powered by GenAI and real world evidence.
PGxAI has raised $1.5M in total funding. The most recent round was Seed. The last funding was announced in December 2024.
PGxAI's investors include Google, Microsoft, Amazon Web Services, Intersystems, ATEM Capital Fund LP.
PGxAI is headquartered in Palo Alto, United States.
Precision medicine platform powered by GenAI and real world evidence.
PGxAI is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PGxAI — Funding & Investors." VCBacked, December 24, 2024, https://www.vcbacked.co/company/pgxai. Accessed August 1, 2026.
VCBacked. (2024). PGxAI — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/pgxai
{{cite web |title=PGxAI — Funding & Investors |url=https://www.vcbacked.co/company/pgxai |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated